
Science Alert - 4 hours 48 min ago
Not your average snake oil.

Wired - 6 hours 19 min ago
These apps, some of which use AI and computer vision, were helpful for meeting my caloric and nutrition intake goals. But they also gave me some anxiety.

Hello Magazine - 7 hours 19 min ago
From weight loss to clear skin to a strong immune system, peptide injections are being touted as a wonder ingredient but how much can they truly help? Doctors explain their efficacy within both the skincare and wellness worlds...

Advocate - 7 hours 49 min ago
Ozempic and other GLP-1 weight-loss medications are being heralded as miracle drugs and they likely are for people with real health concerns but they're also having a distressing negative effect: an increase in toxic body image issues in the queer community.

Science Daily - 17 hours 41 min ago
Stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear. A large real-world study of nearly 8,000 patients found that most people who discontinue these drugs manage to keep the weight off or even continue losing by restarting treatment, switching medications, or adopting lifestyle changes. While earlier clinical trials suggested rapid weight regain, this new evidence paints a more hopeful picture.

The Hill - 22 hours 29 min ago
The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg. The company says the higher dosage is recommended for those who taken the lower dose already for at least four weeks. Novo Nordisk...

E! Online - 22 hours 50 min ago
Khloe Kardashian is keeping it real about her weight loss transformation. While detailing her at-times unhealthy relationship with food, the Kardashians star reflected on her journey to shedding...

CNBC - 23 hours 51 min ago
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

CNBC - 23 hours 56 min ago
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.